These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. A new rat infection-heart transplant model: effect of infection on graft survival studies. Kobayashi J, Mavroudis C, Crawford SE, Zales VR, Backer CL. J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253 [Abstract] [Full Text] [Related]
46. The role of donor and recipient B7-1 (CD80) in allograft rejection. Zheng XX, Sayegh MH, Zheng XG, Li Y, Linsley PS, Peach R, Borriello F, Strom TB, Sharpe AH, Turka LA. J Immunol; 1997 Aug 01; 159(3):1169-73. PubMed ID: 9233610 [Abstract] [Full Text] [Related]
47. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation. Goldstein C, Reiss GR, Mohiuddin M, Shen Z, Yokoyama H, DiSesa VJ. J Surg Res; 1996 Jun 01; 63(1):83-5. PubMed ID: 8661177 [Abstract] [Full Text] [Related]
48. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation. Shen Z, Mohiuddin M, DiSesa VJ. Ann Thorac Surg; 1995 Dec 01; 60(6):1683-5. PubMed ID: 8787463 [Abstract] [Full Text] [Related]
49. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients. Sayegh MH, Zheng XG, Magee C, Hancock WW, Turka LA. Transplantation; 1997 Dec 27; 64(12):1646-50. PubMed ID: 9422396 [Abstract] [Full Text] [Related]
50. Short-course methotrexate and long-term acceptance of fully allogeneic rat cardiac grafts: a possible mechanism of tolerance. Sakuma Y, Xiu D, Uchida H, Hakamata Y, Takahashi M, Murakami T, Nagai H, Kobayashi E. Transpl Immunol; 2002 Jun 27; 10(1):49-54. PubMed ID: 12182465 [Abstract] [Full Text] [Related]
53. Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine. Brunson ME, Tchervenkov JI, Alexander JW. Transplantation; 1991 Sep 27; 52(3):545-9. PubMed ID: 1716800 [Abstract] [Full Text] [Related]
54. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Hoshino Y, Suzuki C, Ohtsuki M, Masubuchi Y, Amano Y, Chiba K. Transplant Proc; 1996 Apr 27; 28(2):1060-1. PubMed ID: 8623226 [No Abstract] [Full Text] [Related]
55. Effect of modulation of donor class II antigen expression on the survival of rat cardiac allografts. Barron PT, Tyerman K, McLeish M, Thiru S, Collier SJ. Transplant Proc; 1990 Aug 27; 22(4):1931-2. PubMed ID: 2117818 [No Abstract] [Full Text] [Related]
56. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status. Yamaguchi Y, Mori K, Bollinger RR. J Clin Lab Immunol; 1990 Jun 27; 32(2):59-66. PubMed ID: 1967040 [Abstract] [Full Text] [Related]
57. Total orthotopic allogeneic small bowel transplantation in rats: effect of allograft irradiation combined with cyclosporine-A therapy. Saat RE, de Bruin RW, Heineman E, Jeekel J, Marquet RL. Gut; 1991 Jun 27; 32(6):654-6. PubMed ID: 2060873 [Abstract] [Full Text] [Related]
59. The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival. Fang YH, Joo DJ, Lim BJ, Huh KH, Kim MS, Suh H, Kim YS. J Surg Res; 2011 Nov 27; 171(1):e133-7. PubMed ID: 21816421 [Abstract] [Full Text] [Related]
60. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens. Shimomura K, Hardy MA, Oluwole SF. Transplantation; 1995 Oct 27; 60(8):806-11. PubMed ID: 7482739 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]